Roche to Acquire InterMune for $74.00/Share in Cash
The Deal:Roche (OTC: RHHBY) and InterMune (NASDAQ: ITMN) announced Sunday that Roche will acquire InterMune for $74.00 per share in cash, for a total transaction value of $8.3 billion. Roche will commence a tender offer no later than August 29, 2014, to acquire all outstanding shares of InterMune common stock, and InterMune will recommend that InterMune's shareholders tender their shares to Roche.
The deal, which was rumored by multiple sources in the past two weeks, has been approved by the boards of both companies, and is expected to close in 2014.
InterMune closed Friday at $53.80, a gain of 1%.